Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.088 USD | -2.67% | +2.71% | -25.68% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MARKER THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.67% | +2.71% | -25.68% | +214.45% | -92.82% | 37.44M |
- Stock Market
- Equities
- MRKR Stock
- Charts Marker Therapeutics, Inc.
- Relative Strength Chart